User menu

Induction of adiponectin in skeletal muscle of type 2 diabetic mice: In vivo and in vitro studies.

Bibliographic reference Delaigle, Aurélie ; Senou, Maximin ; Guiot, Yves ; Many, Marie-Christine ; Brichard, Sonia. Induction of adiponectin in skeletal muscle of type 2 diabetic mice: In vivo and in vitro studies.. In: Diabetologia : clinical and experimental diabetes and metabolism, Vol. 49, no. 6, p. 1311-1323 (2006)
Permanent URL http://hdl.handle.net/2078.1/12786
  1. Lyon CJ, Law RE, Hsueh WA (2003) Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144:2195–2200
  2. Fruebis J, Tsao TS, Javorschi S et al (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 98:2005–2010
  3. Yamauchi T, Kamon J, Minokoshi Y et al (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288–1295
  4. Yamauchi T, Kamon J, Ito Y et al (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762–769
  5. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947–953
  6. Combs Terry P., Berg Anders H., Obici Silvana, Scherer Philipp E., Rossetti Luciano, Endogenous glucose production is inhibited by the adipose-derived protein Acrp30, 10.1172/jci14120
  7. Tomas E, Tsao TS, Saha AK et al (2002) Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA 99:16309–16313
  8. Xu Aimin, Wang Yu, Keshaw Hussila, Xu Lance Yi, Lam Karen S.L., Cooper Garth J.S., The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice, 10.1172/jci200317797
  9. Guerre-Millo M (2004) Adipose tissue and adipokines: for better or worse. Diabetes Metab 30:13–19
  10. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., Hotta K., Nishida M., Takahashi M., Nakamura T., Yamashita S., Funahashi T., Matsuzawa Y., Novel Modulator for Endothelial Adhesion Molecules : Adipocyte-Derived Plasma Protein Adiponectin, 10.1161/01.cir.100.25.2473
  11. Ouchi N., Kihara S., Arita Y., Okamoto Y., Maeda K., Kuriyama H., Hotta K., Nishida M., Takahashi M., Muraguchi M., Ohmoto Y., Nakamura T., Yamashita S., Funahashi T., Matsuzawa Y., Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF- B Signaling Through a cAMP-Dependent Pathway, 10.1161/01.cir.102.11.1296
  12. Yokota T, Oritani K, Takahashi I et al (2000) Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96:1723–1732
  13. Nakanishi S, Yamane K, Kamei N, Nojima H, Okubo M, Kohno N (2005) A protective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane. Metabolism 54:194–199
  14. Motoshima H, Wu X, Mahadev K, Goldstein BJ (2004) Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem Biophys Res Commun 315:264–271
  15. Cnop M., Havel P. J., Utzschneider K. M., Carr D. B., Sinha M. K., Boyko E. J., Retzlaff B. M., Knopp R. H., Brunzell J. D., Kahn S. E., Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex, 10.1007/s00125-003-1074-z
  16. Arita Y, Kihara S, Ouchi N et al (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79–83
  17. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., Iwahashi H., Kuriyama H., Ouchi N., Maeda K., Nishida M., Kihara S., Sakai N., Nakajima T., Hasegawa K., Muraguchi M., Ohmoto Y., Nakamura T., Yamashita S., Hanafusa T., Matsuzawa Y., Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients, 10.1161/01.atv.20.6.1595
  18. Furukawa Shigetada, Fujita Takuya, Shimabukuro Michio, Iwaki Masanori, Yamada Yukio, Nakajima Yoshimitsu, Nakayama Osamu, Makishima Makoto, Matsuda Morihiro, Shimomura Iichiro, Increased oxidative stress in obesity and its impact on metabolic syndrome, 10.1172/jci21625
  19. Ryo M, Nakamura T, Kihara S et al (2004) Adiponectin as a biomarker of the metabolic syndrome. Circ J 68:975–981
  20. Havel PJ (2002) Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol 13:51–59
  21. Delaigle AM, Jonas JC, Bauche IB, Cornu O, Brichard SM (2004) Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. Endocrinology 145:5589–5597
  22. Benson GM, Schiffelers R, Nicols C et al (1998) Effect of probucol on serum lipids, atherosclerosis and toxicology in fat-fed LDL receptor deficient mice. Atherosclerosis 141:237–247
  23. Gerard AC, Many MC, Daumerie C et al (2002) Structural changes in the angiofollicular units between active and hypofunctioning follicles align with differences in the epithelial expression of newly discovered proteins involved in iodine transport and organification. J Clin Endocrinol Metab 87:1291–1299
  24. Leyens G, Donnay I, Knoops B (2003) Cloning of bovine peroxiredoxins—gene expression in bovine tissues and amino acid sequence comparison with rat, mouse and primate peroxiredoxins. Comp Biochem Physiol B Biochem Mol Biol 136:943–955
  25. Weibel E R, Stereological methods in cell biology: where are we--where are we going?, 10.1177/29.9.7026667
  26. Anon (1968) Methods for fats and lipids. In: Luna LG (ed) Manual of histologic staining methods of the Armed Forces Institute of Pathology. 3rd edn. McGraw-Hill, New York, pp 140–142
  27. Uchida Y, Ohba K, Yoshioka T, Irie K, Muraki T, Maru Y (2004) Cellular carbonyl stress enhances the expression of plasminogen activator inhibitor-1 in rat white adipocytes via reactive oxygen species-dependent pathway. J Biol Chem 279:4075–4083
  28. Delporte ML, El Mkadem SA, Quisquater M, Brichard SM (2004) Leptin treatment markedly increased plasma adiponectin but barely decreased plasma resistin of ob/ob mice. Am J Physiol Endocrinol Metab 287:E446–E453
  29. Scoccia AE, Molinuevo MS, McCarthy AD, Cortizo AM (2001) A simple method to assess the oxidative susceptibility of low density lipoproteins. BMC Clin Pathol 1:1
  30. Cani P, Neyrinck A, Maton N, Delzenne N (2005) Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like peptide-1. Obes Res 13:1000–1007
  31. Bailey CJ, Flatt PR (1987) Increased responsiveness to glucoregulatory effect of opiates in obese-diabetic ob/ob mice. Diabetologia 30:33–37
  32. Punyadeera C, Zorenc AH, Koopman R et al (2005) The effects of exercise and adipose tissue lipolysis on plasma adiponectin concentration and adiponectin receptor expression in human skeletal muscle. Eur J Endocrinol 152:427–436
  33. Ide T, Tsunoda M, Mochizuki T, Murakami K (2004) Enhancement of insulin signaling through inhibition of tissue lipid accumulation by activation of peroxisome proliferator-activated receptor (PPAR) alpha in obese mice. Med Sci Monit 10:BR388–BR395
  34. Tsuchida A, Yamauchi T, Ito Y et al (2004) Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 279:30817–30822
  35. Lacquemant Corinne, Vasseur Francis, Lepretre Frederic, Froguel Philippe, Cytokines d’origine adipocytaire, obésité et développement du diabète, 10.1051/medsci/20031989809
  36. Iwaki M, Matsuda M, Maeda N et al (2003) Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52:1655–1663
  37. Maeda N, Takahashi M, Funahashi T et al (2001) PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50:2094–2099
  38. Ferré P, Leturque A, Burnol A F, Penicaud L, Girard J, A method to quantify glucose utilizationin vivoin skeletal muscle and white adipose tissue of the anaesthetized rat, 10.1042/bj2280103
  39. Trostler N, Romsos DR, Bergen WG, Leveille GA (1979) Skeletal muscle accretion and turnover in lean and obese (ob/ob) mice. Metabolism 28:928–933
  40. Breslow MJ, Min-Lee K, Brown DR, Chacko VP, Palmer D, Berkowitz DE (1999) Effect of leptin deficiency on metabolic rate in ob/ob mice. Am J Physiol 276:E443–E449
  41. Harris Ruth B. S., Hausman Dorothy B., Bartness Timothy J., Compensation for partial lipectomy in mice with genetic alterations of leptin and its receptor subtypes, 10.1152/ajpregu.00339.2002
  42. Staiger H, Kausch C, Guirguis A et al (2003) Induction of adiponectin gene expression in human myotubes by an adiponectin-containing HEK293 cell culture supernatant. Diabetologia 46:956–960
  43. Debard C, Laville M, Berbe V et al (2004) Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients. Diabetologia 47:917–925
  44. Rakatzi I, Mueller H, Ritzeler O, Tennagels N, Eckel J (2004) Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1. Diabetologia 47:249–258